Experts laud govt move on vaccination of girls against cervical cancer
Government to encourage vaccination for girls aged 9-14 to prevent cervical cancer.
Union finance minister Nirmala Sithraman on Thursday made a slew of announcements related to healthcare, including vaccination of girl children. Presenting the interim budget for the year 2024-24, Sitharaman said the government plans to set up more medical colleges by utilising existing hospital infrastructure and will set up a committee to examine the matter.

The minister also said that the government will encourage vaccination for girls in the age group of 9-14 years for the prevention of cervical cancer.
"Our Government will encourage vaccination for girls in age group of 9 to 14 years for prevention of cervical cancer," she said, without revealing the details.
Cervical cancer is a type of cancer that begins in the cells lining the cervix, which is the lower part of the uterus (womb) that connects to the vagina. Most cervical cancers are caused by the human papillomavirus (HPV), a sexually transmitted infection. However, not all women with HPV develop cervical cancer, and other factors like smoking, a weakened immune system, and certain genetic factors can increase the risk.
When diagnosed, cervical cancer is one of the most successfully treatable forms of cancer, as long as it is detected early and managed effectively, according to the World Health Organization.
Budget Highlights 2024: Rooftop solarisation, housing for middle class, charging of EVs
WHO Representative to India, Dr Roderico H. Ofrin, applauded the government proposals saying initiatives to upgrade existing hospital infrastructure, harmonization of maternal and child care implementation, and introduction of HPV vaccination for cervical cancer prevention will further strengthen systems and healthcare services across the country.
"WHO welcomes investments in these areas and will continue to support the Government of India in achieving health for all and meeting its disease elimination goals,” he said.
Dr Naresh Trehan, Chairman and Managing Director, Medanta Medicity, lauded the emphasis on anganwadis, women's health, and the vaccination for young girls against cervical cancer.
“All these things are very important addition to what we have. But more importantly, offering of Ayushman coverage for Anganwadi workers and ASHA workers is a big move. I think that will go down very well and boost the morale of our frontline health workers,” he told ANI.
ABOUT THE AUTHORHT News DeskFollow the latest breaking news, major developments and agenda-setting stories from India and around the world with the newsdesk at Hindustan Times. Operating round the clock, the desk brings together experienced editors, reporters and correspondents to deliver fast, accurate and contextual reporting across subjects that influence public policy, governance, business, society and international affairs. The HT News Desk covers politics, elections, government policies, the economy, business and markets, science and technology, the environment, law and order, infrastructure, education, climate issues and geopolitics, while closely tracking developments across states, institutions and global capitals. The team also leads coverage of major breaking news events, policy announcements, court proceedings, natural disasters, public emergencies and significant international developments. Reports published by the newsdesk are based on information gathered from reporters on the ground, official statements, government agencies, court records, regulatory filings, recognised institutions and other authoritative sources. Stories undergo editorial scrutiny and verification processes to ensure accuracy, fairness and relevance, and are updated as events evolve and additional information becomes available. Whether covering a key political decision in New Delhi, an economic policy shift affecting millions, a landmark court ruling or a major global event, the HT News Desk aims to provide readers with reliable, fact-based journalism that delivers not only the latest developments but also the context and analysis needed to understand their wider implications.Read More

E-Paper


